207 related articles for article (PubMed ID: 33069212)
1. Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway.
Fogg KC; Miller AE; Li Y; Flanigan W; Walker A; O'Shea A; Kendziorski C; Kreeger PK
BMC Cancer; 2020 Oct; 20(1):1008. PubMed ID: 33069212
[TBL] [Abstract][Full Text] [Related]
2. Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway.
Fogg KC; Olson WR; Miller JN; Khan A; Renner C; Hale I; Weisman PS; Kreeger PK
Cancer Lett; 2019 Aug; 458():92-101. PubMed ID: 31129149
[TBL] [Abstract][Full Text] [Related]
3. TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer.
Lecker LSM; Berlato C; Maniati E; Delaine-Smith R; Pearce OMT; Heath O; Nichols SJ; Trevisan C; Novak M; McDermott J; Brenton JD; Cutillas PR; Rajeeve V; Hennino A; Drapkin R; Loessner D; Balkwill FR
Cancer Res; 2021 Nov; 81(22):5706-5719. PubMed ID: 34561272
[TBL] [Abstract][Full Text] [Related]
4. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct.
Gundra UM; Girgis NM; Ruckerl D; Jenkins S; Ward LN; Kurtz ZD; Wiens KE; Tang MS; Basu-Roy U; Mansukhani A; Allen JE; Loke P
Blood; 2014 May; 123(20):e110-22. PubMed ID: 24695852
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.
Raghavan S; Mehta P; Xie Y; Lei YL; Mehta G
J Immunother Cancer; 2019 Jul; 7(1):190. PubMed ID: 31324218
[TBL] [Abstract][Full Text] [Related]
6. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors.
Kawamura K; Komohara Y; Takaishi K; Katabuchi H; Takeya M
Pathol Int; 2009 May; 59(5):300-5. PubMed ID: 19432671
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment.
Dijkgraaf EM; Heusinkveld M; Tummers B; Vogelpoel LT; Goedemans R; Jha V; Nortier JW; Welters MJ; Kroep JR; van der Burg SH
Cancer Res; 2013 Apr; 73(8):2480-92. PubMed ID: 23436796
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer.
Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
[TBL] [Abstract][Full Text] [Related]
10. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
[TBL] [Abstract][Full Text] [Related]
11. Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment.
Ciucci A; Zannoni GF; Buttarelli M; Martinelli E; Mascilini F; Petrillo M; Ferrandina G; Scambia G; Gallo D
Oncotarget; 2016 Oct; 7(42):68033-68043. PubMed ID: 27462782
[TBL] [Abstract][Full Text] [Related]
12. A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.
Kreuzinger C; Geroldinger A; Smeets D; Braicu EI; Sehouli J; Koller J; Wolf A; Darb-Esfahani S; Joehrens K; Vergote I; Vanderstichele A; Boeckx B; Lambrechts D; Gabra H; Wisman GBA; Trillsch F; Heinze G; Horvat R; Polterauer S; Berns E; Theillet C; Cacsire Castillo-Tong D
Clin Cancer Res; 2017 Dec; 23(24):7621-7632. PubMed ID: 28972047
[No Abstract] [Full Text] [Related]
13. Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells.
Carroll MJ; Fogg KC; Patel HA; Krause HB; Mancha AS; Patankar MS; Weisman PS; Barroilhet L; Kreeger PK
Cancer Res; 2018 Jul; 78(13):3560-3573. PubMed ID: 29739756
[TBL] [Abstract][Full Text] [Related]
14. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.
Reinartz S; Schumann T; Finkernagel F; Wortmann A; Jansen JM; Meissner W; Krause M; Schwörer AM; Wagner U; Müller-Brüsselbach S; Müller R
Int J Cancer; 2014 Jan; 134(1):32-42. PubMed ID: 23784932
[TBL] [Abstract][Full Text] [Related]
15. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
Soldano S; Pizzorni C; Paolino S; Trombetta AC; Montagna P; Brizzolara R; Ruaro B; Sulli A; Cutolo M
PLoS One; 2016; 11(11):e0166433. PubMed ID: 27846260
[TBL] [Abstract][Full Text] [Related]
16. Omental Macrophagic "Crown-like Structures" Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer.
Liang YL; Lin CN; Tsai HF; Wu PY; Lin SH; Hong TM; Hsu KF
Curr Oncol; 2021 Oct; 28(5):4234-4246. PubMed ID: 34677277
[TBL] [Abstract][Full Text] [Related]
17. Colon cancer-derived conditioned medium induces differentiation of THP-1 monocytes into a mixed population of M1/M2 cells.
Sawa-Wejksza K; Dudek A; Lemieszek M; Kaławaj K; Kandefer-Szerszeń M
Tumour Biol; 2018 Sep; 40(9):1010428318797880. PubMed ID: 30183516
[TBL] [Abstract][Full Text] [Related]
18. Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.
Surówka J; Wertel I; Okła K; Bednarek W; Tarkowski R; Kotarski J
Clin Transl Oncol; 2017 Dec; 19(12):1489-1497. PubMed ID: 28589429
[TBL] [Abstract][Full Text] [Related]
19. Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages.
Abumaree MH; Al Jumah MA; Kalionis B; Jawdat D; Al Khaldi A; Abomaray FM; Fatani AS; Chamley LW; Knawy BA
Stem Cell Rev Rep; 2013 Oct; 9(5):620-41. PubMed ID: 23812784
[TBL] [Abstract][Full Text] [Related]
20. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
Rahal OM; Wolfe AR; Mandal PK; Larson R; Tin S; Jimenez C; Zhang D; Horton J; Reuben JM; McMurray JS; Woodward WA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1034-1043. PubMed ID: 29485045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
